Skip to main content
OpenTrials

Clinical trial condition

Bronchial Neoplasms

Explore clinical trials studying Bronchial Neoplasms. Study availability and eligibility vary by location and protocol.

5,246 public trials 1,181 recruiting studies
Refine in advanced search Browse all conditions

Bronchial Neoplasms trial results

Completed

Docetaxel and Carboplatin Versus Docetaxel as Second Line Treatment in Patients With Non-Small-Cell Lung Carcinoma (NSCLC)

NCT00430651

Conditions
Bronchial Neoplasms, Carcinoma, Bronchogenic, Carcinoma, Non-Small-Cell Lung, +8 more
Locations
  • University Hospital of Crete Heraklion, Crete, Greece
  • University General Hospital of Alexandroupolis, Dep of Medical Oncology Alexandroupoli, Greece
  • "IASO" General Hospital of Athnes, Dep of Medical Oncology Athens, Greece
  • "Laikon" General Hospital, Medical Oncology Unit, Propedeutic Dep of Internal Medicine Athens, Greece
View Trial Details
Completed

Picoplatin as Second-Line Therapy for Patients With Small Cell Lung Cancer

NCT00116610

Conditions
Bronchial Neoplasms, Carcinoma, Bronchogenic, Disease Attributes, +14 more
Locations
  • Genesis Cancer Center Hot Springs, Arkansas, United States
  • Study Site Los Angeles, California, United States
  • Comprehensive Cancer Center Palm Springs, California, United States
  • Eastern Connecticut Hematology/Oncology Norwich, Connecticut, United States
View all 55 locations
View Trial Details
Completed

Evaluation of the Overall Survival of Meclinertant Versus Placebo After a First Line Chemotherapy With Cisplatin + Etoposide

NCT00290953

Conditions
Bronchial Neoplasms, Carcinoma, Bronchogenic, Lung Cancer, +14 more
Locations
  • Sanofi-Aventis Administrative Office Buenos Aires, Argentina
  • Sanofi-Aventis Administrative Office Macquarie Park, Australia
  • Sanofi-Aventis Administrative Office Diegem, Belgium
  • Sanofi-Aventis Administrative Office São Paulo, Brazil
View all 14 locations
View Trial Details
Completed

STA-4783 in Combination With Paclitaxel and Carboplatin for the Treatment of Chemotherapy Naive Patients With Stage IIIB/IV Non Small Cell Lung Cancer (NSCLC)

NCT00088088

Conditions
Bronchial Neoplasms, Carcinoma, Bronchogenic, Carcinoma, Non-Small-Cell Lung, +9 more
Locations
  • NEA Clinic Jonesboro, Arkansas, United States
  • Wilshire Oncology Medical Group Pomona, California, United States
  • St. Francis Memorial Hospital San Francisco, California, United States
  • Cancer Institute Medical Group Santa Monica, California, United States
View all 19 locations
View Trial Details
Completed

Study Of SU011248 In Combination With Docetaxel In Patients With Advanced Cancer

NCT00712504

Conditions
Advanced Solid Tumors, Bronchial Neoplasms, Carcinoma, Bronchogenic, +9 more
Locations
  • Pfizer Investigational Site Birmingham, Alabama, United States
  • Pfizer Investigational Site Birmingham, Alabama, United States
  • Pfizer Investigational Site Birmingham, Alabama, United States
  • Pfizer Investigational Site Nashville, Tennessee, United States
View Trial Details
Completed

Randomized Trial With Vinorelbine and Gemcitabine Versus Docetaxel and Gemcitabine in Patients With Non-Small Cell Lung Cancer

NCT00441740

Conditions
Bronchial Neoplasms, Carcinoma, Bronchogenic, Carcinoma, Non-Small-Cell Lung, +8 more
Locations
  • University General Hospital of Alexandroupolis, Dep of Medical Oncology Alexandroupoli, Greece
  • " General Hospital, 1st, 3rd, 8th Dep of Pulmonary Diseases Athens, Greece
  • "Laikon" General Hospital, Medical Oncology Unit, Propedeutic Dep of Internal Medicine Athens, Greece
  • "Metaxa's" Anticancer Hospital of Piraeus,1st Dep of Medical Oncology Athens, Greece
View Trial Details

Related conditions